Related Experiment Video
Updated: Aug 17, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Novel approaches for the treatment of non-small cell lung cancer
1Department of Medical Oncology, Rush Cancer Institute, Chicago, IL 60612-3824, USA.
Abstract:
Non-small cell lung cancer is a major worldwide health problem. Approximately 80% of non-small cell lung cancer patients present with advanced disease for which there is little or no chance of cure. Although survival in stage IV non-small cell lung cancer patients is prolonged by treatment with combination chemotherapy regimens, all of these patients develop disease that is refractory to currently available systemic therapy. Basic scientists have identified a number of new therapeutic targets that offer the potential for novel therapeutic interventions, which might control chemotherapy-refractory disease or potentiate the effectiveness of chemotherapy and radiation therapy. The new targets include tumor-associated angiogenesis, biochemical pathways that stimulate tumor proliferation, and programmed cell death (apoptosis). Each of these novel targets will be discussed briefly in this review.
Insights
Advanced non-small cell lung cancer (NSCLC) often becomes resistant to chemotherapy. New therapeutic targets, including tumor angiogenesis and apoptosis, show promise for treating chemotherapy-refractory NSCLC.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) represents a significant global health challenge.
- Most NSCLC patients are diagnosed with advanced disease, limiting curative options.
- Current chemotherapy regimens offer survival benefits but ultimately lead to treatment resistance in stage IV NSCLC.
Purpose of the Study:
- To review novel therapeutic targets for non-small cell lung cancer.
- To explore potential interventions for chemotherapy-refractory NSCLC.
- To discuss targets including tumor angiogenesis, proliferation pathways, and apoptosis.
Main Methods:
- Literature review of current research on NSCLC therapeutic targets.
- Analysis of basic science findings related to novel intervention strategies.
- Discussion of targets for potentiating chemotherapy and radiation therapy.
Main Results:
- Identification of key molecular targets in NSCLC.
- Potential for novel therapies to overcome chemotherapy resistance.
- Strategies to enhance the efficacy of existing treatments.
Conclusions:
- Novel therapeutic targets offer hope for managing advanced NSCLC.
- Targeting angiogenesis, proliferation, and apoptosis may improve patient outcomes.
- Further research into these targets is crucial for developing new treatments.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy